NICOLE HAWKINS: Open Payments
NPI 1255701538 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,286 in 183 payments from 36 companies in 2025. Trend: 2023 $983 · 2024 $3,002 · 2025 $3,286
Food & beverage: $3,241Education: $45
| Company | Payments | Amount |
|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | 35 | $524 |
| Amgen Inc. | 26 | $512 |
| Xeris Pharmaceuticals, Inc. | 16 | $332 |
| Lilly USA, LLC | 15 | $289 |
| Abbott Laboratories | 27 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $234 |
| Corcept Therapeutics | 8 | $141 |
| Alexion Pharmaceuticals, Inc. | 4 | $107 |
| Madrigal Pharmaceuticals | 4 | $95 |
| Radius Health, Inc. | 4 | $69 |
Products named: ISTURISA, TEPEZZA, FREESTYLE LIBRE 3, Kerendia, RECORLEV, REPATHA, JARDIANCE, Korlym.
Industry payments across IN — which companies pay providers there.
